Vaishali Pharma Limited (NSE:VAISHALI)
11.60
+0.06 (0.52%)
Jun 30, 2025, 3:29 PM IST
Vaishali Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 18.43 | 14.57 | 5.29 | 11.62 | 3.13 | Upgrade
|
Cash & Short-Term Investments | 18.43 | 14.57 | 5.29 | 11.62 | 3.13 | Upgrade
|
Cash Growth | 26.50% | 175.35% | -54.48% | 270.76% | 10.69% | Upgrade
|
Accounts Receivable | 467.17 | 494.27 | 536.1 | 585.05 | 667.31 | Upgrade
|
Other Receivables | 0.18 | 5.13 | 3.72 | 3.18 | 4.84 | Upgrade
|
Receivables | 467.35 | 499.41 | 539.82 | 588.23 | 672.14 | Upgrade
|
Inventory | 48.1 | 3.8 | 30.5 | 6.29 | 5.88 | Upgrade
|
Prepaid Expenses | - | 0.43 | 0.53 | 0.69 | 0.05 | Upgrade
|
Other Current Assets | 510.96 | 227 | 150.57 | 157.45 | 131.74 | Upgrade
|
Total Current Assets | 1,045 | 745.2 | 726.71 | 764.29 | 812.95 | Upgrade
|
Property, Plant & Equipment | 11.61 | 14.55 | 17.98 | 9.04 | 9.71 | Upgrade
|
Long-Term Investments | 4.32 | 17.53 | 16.38 | 10.82 | 10.81 | Upgrade
|
Other Intangible Assets | 9.23 | 8.02 | 8.56 | 7.69 | 2.94 | Upgrade
|
Long-Term Deferred Tax Assets | 1.84 | 1.76 | 1.43 | 1.61 | 1.48 | Upgrade
|
Other Long-Term Assets | 26.62 | 12.51 | 17.92 | 22.81 | 23.37 | Upgrade
|
Total Assets | 1,098 | 799.56 | 788.98 | 816.24 | 861.26 | Upgrade
|
Accounts Payable | 271.45 | 193.89 | 179.97 | 283.81 | 405.37 | Upgrade
|
Accrued Expenses | 2.8 | 13.15 | 17.42 | 21.15 | 26.52 | Upgrade
|
Short-Term Debt | - | 76.19 | 73.42 | 166.94 | 116.24 | Upgrade
|
Current Portion of Long-Term Debt | 74.64 | 13.92 | 10.94 | 9.62 | 19.17 | Upgrade
|
Current Portion of Leases | 2.35 | 6.46 | 1.91 | 0.12 | 0.49 | Upgrade
|
Current Income Taxes Payable | - | - | 19.46 | 12.72 | 3.77 | Upgrade
|
Current Unearned Revenue | - | 27.21 | 17.56 | 25.02 | 21.07 | Upgrade
|
Other Current Liabilities | 49.29 | -0 | -0 | - | - | Upgrade
|
Total Current Liabilities | 400.53 | 330.82 | 320.68 | 519.37 | 592.63 | Upgrade
|
Long-Term Debt | 41.95 | 35.98 | 52.27 | 31.06 | 40.33 | Upgrade
|
Long-Term Leases | 4.24 | 2.36 | 8.82 | 0.38 | 2.26 | Upgrade
|
Other Long-Term Liabilities | - | 0 | 0 | 0 | 0 | Upgrade
|
Total Liabilities | 449.29 | 371.16 | 383.66 | 552.7 | 637.07 | Upgrade
|
Common Stock | 260.92 | 107.19 | 105.46 | 105.46 | 105.46 | Upgrade
|
Additional Paid-In Capital | - | 100.02 | 80.73 | 80.98 | 82.02 | Upgrade
|
Retained Earnings | - | 149.11 | 141.92 | 75.89 | 35.65 | Upgrade
|
Comprehensive Income & Other | 388.24 | 72.07 | 77.21 | 1.22 | 1.05 | Upgrade
|
Shareholders' Equity | 649.16 | 428.39 | 405.32 | 263.54 | 224.19 | Upgrade
|
Total Liabilities & Equity | 1,098 | 799.56 | 788.98 | 816.24 | 861.26 | Upgrade
|
Total Debt | 123.18 | 134.92 | 147.36 | 208.11 | 178.5 | Upgrade
|
Net Cash (Debt) | -104.76 | -120.35 | -142.07 | -196.49 | -175.36 | Upgrade
|
Net Cash Per Share | -3.97 | -1.07 | -1.27 | -1.86 | -1.66 | Upgrade
|
Filing Date Shares Outstanding | 13.54 | 107.19 | 105.46 | 105.46 | 105.46 | Upgrade
|
Total Common Shares Outstanding | 13.54 | 107.19 | 105.46 | 105.46 | 105.46 | Upgrade
|
Working Capital | 644.31 | 414.38 | 406.04 | 244.92 | 220.33 | Upgrade
|
Book Value Per Share | 47.94 | 4.00 | 3.84 | 2.50 | 2.13 | Upgrade
|
Tangible Book Value | 639.93 | 420.38 | 396.76 | 255.85 | 221.25 | Upgrade
|
Tangible Book Value Per Share | 47.26 | 3.92 | 3.76 | 2.43 | 2.10 | Upgrade
|
Buildings | - | 7.25 | 7.25 | 7.25 | 7.25 | Upgrade
|
Machinery | - | 11.56 | 11.14 | 10.11 | 7.46 | Upgrade
|
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.